Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals

Oncology Drugs - APAC

APAC
  • Revenue in the Oncology Drugs market is projected to reach US$42.61bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 14.38%, resulting in a market volume of US$72.91bn by 2028.
  • In global comparison, most revenue will be generated United States (US$103.90bn in 2024).

Definition:
The Oncology Drugs market covers drugs to treat cancer, including chemotherapy and immunotherapy. These therapies are used for solid tumors and hematologic cancer. The medications in this market are mainly physician-administered drugs.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Bristol-Myers Squibb, Roche, Merck & Co, Novartis, Johnson & Johnson

In-Scope

  • Treatment for different types of cancer, including skin cancer, leukemia, lymphoma, and multiple myeloma
  • Chemotherapeutic agents
  • Immuno-oncology drugs
  • Oncology orphan drugs

Out-Of-Scope

  • Radiation therapy
  • Medical devices
Pharmaceuticals

Pharmaceuticals

Related markets:
Oncology Drugs: market data & analysis - Cover

Market Insights report

Oncology Drugs: market data & analysis

Study Details
    methodology

    Download PDF

    FAQs and more info on the methodology

    Revenue

    Notes: Data was converted from local currencies using average exchange rates of the respective year.

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Analyst Opinion

    Oncology Drugs is the largest market of the Pharmaceuticals market. Its growth rate is expected to remain very high. This growth is mainly driven by immuno-oncology. The market is dominated by a comparatively small number of high-priced drugs, which makes individual therapies typically very expensive. Most of the revenue is generated in wealthier countries. For several leading pharmaceutical companies, oncology is their largest market.

    As a result of the COVID-19 pandemic, the market size is somewhat lower than previously expected. This is because of the decreased accessibility to physician-administered drugs. Moreover, due to fewer medical consultations and screenings, a smaller number of new cases were detected.

    Global Comparison

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Oncology Drugs: market data & analysis - BackgroundOncology Drugs: market data & analysis - Cover

    Explore more high-quality data on related topic

    Cancer worldwide - Statistics & Facts

    Cancer is one of the leading causes of death worldwide, with lung cancer alone ranked the sixth leading cause of death in 2021. Cancer, also known as malignant tumors and neoplasms, is the result of interactions between personal genetic factors and external agents causing abnormal transformations of cells into tumors over time. As the global population has increased in age, the incidence of new cancer cases has also risen, contributing to a higher number of deaths each year. In 2022, nearly 10 million deaths were caused by cancer worldwide- a number which is expected to reach over 15 million by 2040.
    More data on the topic
    Cancer type with the highest number of new cases worldwide in 2022
    Trachea, bronchus and lung
    Cancer type causing the highest share of cancer deaths worldwide
    Lung cancer
    Global oncology spending in 2022
    193bn USD

    Contact

    Get in touch with us. We are happy to help.